MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

340.03 -0.02

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

337.13

Max

341.6

Belangrijke statistieken

By Trading Economics

Inkomsten

-1B

-340M

Verkoop

3.1B

84B

K/W

Sectorgemiddelde

42.717

78.892

EPS

3.84

Dividendrendement

0.65

Winstmarge

-0.406

Werknemers

47,000

EBITDA

-1.1B

150M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+15.18% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.65%

2.38%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-135M

66B

Vorige openingsprijs

340.05

Vorige sluitingsprijs

340.03

Nieuwssentiment

By Acuity

17%

83%

16 / 374 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 dec 2025, 22:03 UTC

Belangrijke Marktbewegers

Mining Stocks Slip Near the End of Stellar Year

29 dec 2025, 15:57 UTC

Belangrijke Marktbewegers

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dec 2025, 23:43 UTC

Marktinformatie

Nikkei May Decline; Yen in Focus -- Market Talk

29 dec 2025, 23:38 UTC

Acquisities, Fusies, Overnames

Manus: Will Continue to Operate From Singapore

29 dec 2025, 23:38 UTC

Acquisities, Fusies, Overnames

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dec 2025, 23:37 UTC

Acquisities, Fusies, Overnames

Meta Platforms: Will Integrate Manus Service Into Products

29 dec 2025, 23:36 UTC

Acquisities, Fusies, Overnames

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dec 2025, 23:36 UTC

Acquisities, Fusies, Overnames

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dec 2025, 23:35 UTC

Acquisities, Fusies, Overnames

Manus to Join Meta Platforms

29 dec 2025, 21:33 UTC

Acquisities, Fusies, Overnames

Origin: Raise Values Kraken at US$8.65 Billion

29 dec 2025, 21:33 UTC

Acquisities, Fusies, Overnames

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dec 2025, 21:31 UTC

Acquisities, Fusies, Overnames

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dec 2025, 21:31 UTC

Acquisities, Fusies, Overnames

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dec 2025, 21:30 UTC

Acquisities, Fusies, Overnames

Origin's Kraken Stake to Remain at 22.7%

29 dec 2025, 21:30 UTC

Acquisities, Fusies, Overnames

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dec 2025, 21:30 UTC

Acquisities, Fusies, Overnames

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dec 2025, 21:30 UTC

Acquisities, Fusies, Overnames

Origin: Additional Interest Offsets Dilution From Raise

29 dec 2025, 21:30 UTC

Acquisities, Fusies, Overnames

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dec 2025, 21:29 UTC

Acquisities, Fusies, Overnames

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dec 2025, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dec 2025, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dec 2025, 21:27 UTC

Acquisities, Fusies, Overnames

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dec 2025, 20:22 UTC

Marktinformatie

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dec 2025, 20:14 UTC

Marktinformatie

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dec 2025, 20:02 UTC

Acquisities, Fusies, Overnames

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dec 2025, 17:36 UTC

Marktinformatie

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

15.18% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 392.82 USD  15.18%

Hoogste 417 USD

Laagste 361 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

16 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat